Mechanism of Membrane Fusion by Viral Envelope Proteins

Advances in Virus Research

Volumn 64, Issue , 2005, Pages 231-261

  Harrison, Stephen C ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ENVELOPE PROTEIN; VIRUS RECEPTOR;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL FUSION; MEMBRANE FUSION; PATHOGENICITY; PHYSIOLOGY; VIRUS;

ANIMALS; CELL FUSION; MEMBRANE FUSION; RECEPTORS, VIRUS; VIRAL ENVELOPE PROTEINS; VIRUSES;

EID: 26944466459     PISSN: 00653527     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-3527(05)64007-9     Document Type: Review

References (85)

1. Ahn A., Gibbons D.L., and Kielian M. The fusion peptide of Semliki Forest virus associates with sterol-rich membrane domains. J. Virol. 76 (2002) 3267-3275
2. Allan J.S., Coligan J.E., Barin F., McLane M.F., Sodroski J.G., Rosen C.A., Haseltine W.A., Lee T.H., and Essex M. Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Science 228 (1985) 1091-1094
3. Allison S.L., Schalich J., Stiasny K., Mandl C.W., and Heinz F.X. Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J. Virol. 75 (2001) 4268-4275
4. Allison S.L., Schalich J., Stiasny K., Mandl C.W., Kunz C., and Heinz F.X. Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH. J. Virol. 69 (1995) 695-700
5. Allison S.L., Stiasny K., Stadler K., Mandl C.W., and Heinz F.X. Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E. J. Virol. 73 (1999) 5605-5612
6. Armstrong R.T., Kushnir A.S., and White J.M. The transmembrane domain of influenza hemagglutinin exhibits a stringent length requirement to support the hemifusion to fusion transition. J. Cell Biol. 151 (2000) 425-437
7. Blacklow S.C., Lu M., and Kim P.S. A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein. Biochemistry 34 (1995) 14955-14962
8. Bressanelli S., Stiasny K., Allison S.L., Stura E.A., Duquerroy S., Lescar J., Heinz F.X., and Rey F.A. Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J. 23 (2004) 728-738
9. Bullough P.A., Hughson F.M., Skehel J.J., and Wiley D.C. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371 (1994) 37-43
10. Caffrey M., Cai M., Kaufman J., Stahl S.J., Wingfield P.T., Covell D.G., Gronenborn A.M., and Clore G.M. Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41. EMBO J. 17 (1998) 4572-4584
11. Carr C.M., and Kim P.S. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell 73 (1993) 823-832
12. Chan D.C., Chutkowski C.T., and Kim P.S. Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target. Proc. Natl. Acad. Sci. USA 95 (1998) 15613-15617
13. Chan D.C., Fass D., Berger J.M., and Kim P.S. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89 (1997) 263-273
14. 2 subunit to form an N cap that terminates the triple-stranded coiled coil. Proc. Natl. Acad. Sci. USA 96 (1999) 8967-8972
15. Cohen F.S., Markosyan R.M., and Melikyan G.B. The process of membrane fusion: Nipples, hemifusion, pores, and pore growth. Curr. Top. Membr. 52 (2002) 501-529
16. Dalgleish A.G., Beverley P.C., Clapham P.R., Crawford D.H., Greaves M.F., and Weiss R.A. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312 (1984) 763-767
17. Danieli T., Pelletier S.L., Henis Y.I., and White J.M. Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers. J. Cell Biol. 133 (1996) 559-569
18. Daniels R.S., Downie J.C., Hay A.J., Knossow M., Skehel J.J., Wang M.L., and Wiley D.C. Fusion mutants of the influenza virus hemagglutinin glycoprotein. Cell 40 (1985) 431-439
19. Dutch R.E., and Lamb R.A. Deletion of the cytoplasmic tail of the fusion protein of the paramyxovirus simian virus 5 affects fusion pore enlargement. J. Virol. 75 (2001) 5363-5369
20. Eckert D.M., Malashkevich V.N., Hong L.H., Carr P.A., and Kim P.S. Inhibiting HIV-1 entry: Discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket. Cell 99 (1999) 103-115
21. Fass D., Harrison S.C., and Kim P.S. Retrovirus envelope domain at 1.7 Å resolution. Nat. Struct. Biol. 3 (1996) 465-469
22. Feng Y., Broder C.C., Kennedy P.E., and Berger E.A. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272 (1996) 872-877
23. Ferrer M., Kapoor T.M., Strassmaier T., Weissenhorn W., Skehel J.J., Oprian D., Schreiber S.L., Wiley D.C., and Harrison S.C. Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements. Nat. Struct. Biol. 6 (1999) 953-960
24. Furuta R.A., Wild C.T., Weng Y., and Weiss C.D. Capture of an early fusion-active conformation of HIV-1 gp41. Nat. Struct. Biol. 5 (1998) 276-279
25. Gibbons D.L., Ahn A., Liao M., Hammar L., Cheng R.H., and Kielian M. Multistep regulation of membrane insertion of the fusion peptide of Semliki Forest virus. J. Virol. 78 (2004) 3312-3318
26. Gibbons D.L., Erk I., Reilly B., Navaza J., Kielian M., Rey F.A., and Lepault J. Visualization of the target-membrane-inserted fusion protein of Semliki Forest virus by combined electron microscopy and crystallography. Cell 114 (2003) 573-583
27. Gibbons D.L., Vaney M.C., Roussel A., Vigouroux A., Reilly B., Lepault J., Kielian M., and Rey F.A. Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus. Nature 427 (2004) 320-325
28. Han X., Bushweller J.H., Cafiso D.S., and Tamm L.K. Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin. Nat. Struct. Biol. 8 (2001) 715-720
29. Heinz F.X., Mandl C.W., Holzmann H., Kunz C., Harris B.A., Rey F., and Harrison S.C. The flavivirus envelope protein E: Isolation of a soluble form from tick-borne encephalitis virus and its crystallization. J. Virol. 65 (1991) 5579-5583
30. Heinz F.X., Stiasny K., Puschner-Auer G., Holzmann H., Allison S.L., Mandl C.W., and Kunz C. Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM. Virology 198 (1994) 109-117
31. Jahn R., Lang T., and Sudhof T.C. Membrane fusion. Cell 112 (2003) 519-533
32. Jiang S., Lin K., Strick N., and Neurath A.R. HIV-1 inhibition by a peptide. Nature 365 (1993) 113
33. Jones P.L., Korte T., and Blumenthal R. Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors. J. Biol. Chem. 273 (1998) 404-409
34. Kemble G.W., Danieli T., and White J.M. Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion. Cell 76 (1994) 383-391
35. Kilby J.M., and Eron J.J. Novel therapies based on mechanisms of HIV-1 cell entry. N. Engl. J. Med. 348 (2003) 2228-2238
36. Kliger Y., Gallo S.A., Peisajovich S.G., Munoz-Barroso I., Avkin S., Blumenthal R., and Shai Y. Mode of action of an antiviral peptide from HIV-1: Inhibition at a post-lipid mixing stage. J. Biol. Chem. 276 (2001) 1391-1397
37. Klimjack M.R., Jeffrey S., and Kielian M. Membrane and protein interactions of a soluble form of the Semliki Forest virus fusion protein. J. Virol. 68 (1994) 6940-6946
38. Kuhn R.J., Zhang W., Rossmann M.G., Pletnev S.V., Corver J., Lenches E., Jones C.T., Mukhopadhyay S., Chipman P.R., Strauss E.G., Baker T.S., and Strauss J.H. Structure of dengue virus: Implications for flavivirus organization, maturation, and fusion. Cell 108 (2002) 717-725
39. Kuzmin P.I., Zimmerberg J., Chizmadzhev Y.A., and Cohen F.S. A quantitative model for membrane fusion based on low-energy intermediates. Proc. Natl. Acad. Sci. USA 98 (2001) 7235-7240
40. Kwong P.D., Wyatt R., Majeed S., Robinson J., Sweet R.W., Sodroski J., and Hendrickson W.A. Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates. Struct. Fold. Des. 8 (2000) 1329-1339
41. Kwong P.D., Wyatt R., Robinson J., Sweet R.W., Sodroski J., and Hendrickson W.A. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393 (1998) 648-659
42. Lescar J., Roussel A., Wien M.W., Navaza J., Fuller S.D., Wengler G., and Rey F.A. The fusion glycoprotein shell of Semliki Forest virus: An icosahedral assembly primed for fusogenic activation at endosomal pH. Cell 105 (2001) 137-148
43. Lu M., Blacklow S.C., and Kim P.S. A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat. Struct. Biol. 2 (1995) 1075-1082
44. Markin V.S., Kozlov M.M., and Borovjagin V.L. On the theory of membrane fusion: The stalk mechanism. Gen. Physiol. Biophys. 5 (1984) 361-377
45. Melikyan G.B., White J.M., and Cohen F.S. GPI-anchored influenza hemagglutinin induces hemifusion to both red blood cell and planar bilayer membranes. J. Cell Biol. 131 (1995) 679-691
46. Modis Y., Ogata S., Clements D., and Harrison S.C. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc. Natl. Acad. Sci. USA 100 (2003) 6986-6991
47. Modis Y., Ogata S., Clements D., and Harrison S.C. Structure of the dengue virus envelope protein after membrane fusion. Nature 427 (2004) 313-319
48. Moore J.P., McKeating J.A., Weiss R.A., and Sattentau Q.J. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science 250 (1990) 1139-1142
49. Munoz-Barroso I., Salzwedel K., Hunter E., and Blumenthal R. Role of the membrane-proximal domain in the initial stages of human immunodeficiency virus type 1 envelope glycoprotein-mediated membrane fusion. J. Virol. 73 (1999) 6089-6092
50. Myszka D.G., Sweet R.W., Hensley P., Brigham-Burke M., Kwong P.D., Hendrickson W.A., Wyatt R., Sodroski J., and Doyle M.L. Energetics of the HIV gp120-CD4 binding reaction. Proc. Natl. Acad. Sci. USA 97 (2000) 9026-9031
51. Pletnev S.V., Zhang W., Mukhopadhyay S., Fisher B.R., Hernandez R., Brown D.T., Baker T.S., Rossmann M.G., and Kuhn R.J. Locations of carbohydrate sites on alphavirus glycoproteins show that E1 forms an icosahedral scaffold. Cell 105 (2001) 127-136
52. Pollard S.R., Rosa M.D., Rosa J.J., and Wiley D.C. Truncated variants of gp120 bind CD4 with high affinity and suggest a minimum CD4 binding region. EMBO J. 11 (1992) 585-591
53. Qiao H., Armstrong R.T., Melikyan G.B., Cohen F.S., and White J.M. A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype. Mol. Biol. Cell 10 (1999) 2759-2769
54. Rey F.A., Heinz F.X., Mandl C., Kunz C., and Harrison S.C. The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature 375 (1995) 291-298
55. Rimsky L.T., Shugars D.C., and Matthews T.J. Determinants of human immunodeficiency virus type-I resistance to gp41-derived inhibitory peptides. J. Virol. 72 (1998) 986-993
56. Rizzuto C.D., Wyatt R., Hernandez-Ramos N., Sun Y., Kwong P.D., Hendrickson W.A., and Sodroski J. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 280 (1998) 1949-1953
57. Robey W.G., Safai B., Oroszlan S., Arthur L.O., Gonda M.A., Gallo R.C., and Fischinger P.J. Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients. Science 228 (1985) 593-595
58. Root M.J., Kay M.S., and Kim P.S. Protein design of an HIV-1 entry inhibitor. Science 291 (2001) 884-888
59. Rosenthal P.B., Zhang X., Formanowski F., Fitz W., Wong C.H., Meier-Ewert H., Skehel J.J., and Wiley D.C. Structure of the haemagglutinin-esterase-fusion glycoprotein of influenza C virus. Nature 396 (1998) 92-96
60. Samsonov A.V., Chatterjee P.K., Razinkob V.I., Eng C.H., Kielian M., and Cohen F.S. Effects of membrane potential and sphingolipid structures on fusion of Semliki Forest virus. J. Virol. 76 (2002) 12691-12702
61. Sattentau Q.J., and Moore J.P. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J. Exp. Med. 174 (1991) 407-415
62. Sattentau Q.J., Moore J.P., Vignaux F., Traincard F., and Poignard P. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding. J. Virol. 67 (1993) 7383-7393
63. Siegel D.P. Energetics of intermediates in membrane fusion: Comparison of stalk and inverted micellar intermediate mechanisms. Biophys. J. 65 (1993) 2124-2140
64. Skehel J.J., and Wiley D.C. Coiled coils in both intracellular vesicle and viral membrane fusion. Cell 95 (1998) 871-874
65. Skehel J.J., and Wiley D.C. Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin. Annu. Rev. Biochem. 69 (2000) 531-569
66. Steinhauer D.A., Wharton S.A., Skehel J.J., and Wiley D.C. Studies of the membrane fusion activities of fusion peptide mutants of influenza virus hemagglutinin. J. Virol. 69 (1995) 6643-6651
67. Stiasny K., Allison S.L., Schalich J., and Heinz F.X. Membrane interactions of the tick-borne encephalitis virus fusion protein E at low pH. J. Virol. 76 (2002) 3784-3790
68. Stiasny K., Bressanelli S., Lepault J., Rey F.A., and Heinz F.X. Characterization of a membrane-associated trimeric low-pH induced form of the class II viral fusion protein E from tick-borne encephalitis virus and its crystallization. J. Virol. 78 (2004) 3178-3183
69. Tan K., Liu J., Wang J., Shen S., and Lu M. Atomic structure of a thermostable subdomain of HIV-1 gp41. Proc. Natl. Acad. Sci. USA 94 (1997) 12303-12308
70. Trkola A., Dragic T., Arthos J., Binley J.M., Olson W.C., Allaway G.P., Cheng-Mayer C., Robinson J., Maddon P.J., and Moore J.P. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 384 (1996) 184-187
71. 2-terminal segment during influenza virus-induced membrane fusion. J. Biol. Chem. 267 (1992) 20225-20232
72. Vashishtha M., Phalen T., Marquardt M.T., Ryu J.S., Ng A.C., and Kielian M. A single point mutation controls the cholesterol dependence of Semliki Forest virus entry and exit. J. Cell Biol. 140 (1998) 91-99
73. Veronese F.D., DeVico A.L., Copeland T.D., Oroszlan S., Gallo R.C., and Sarngadharan M.G. Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene. Science 229 (1985) 1402-1405
74. Wahlberg J.M., Boere W.A., and Garoff H. The heterodimeric association between the membrane proteins of Semliki Forest virus changes its sensitivity to low pH during virus maturation. J. Virol. 63 (1989) 4991-4997
75. Wahlberg J.M., Bron R., Wilschut J., and Garoff H. Membrane fusion of Semliki Forest virus involves homotrimers of the fusion protein. J. Virol. 66 (1992) 7309-7318
76. Watanabe S., Takada A., Watanabe T., Ito H., Kida H., and Kawaoka Y. Functional importance of the coiled-coil of the Ebola virus glycoprotein. J. Virol. 74 (2000) 10194-10201
77. Weissenhorn W., Carfi A., Lee K.H., Skehel J.J., and Wiley D.C. Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. Mol. Cell 2 (1998) 605-616
78. Weissenhorn W., Dessen A., Harrison S.C., Skehel J.J., and Wiley D.C. Atomic structure of the ectodomain from HIV-1 gp41. Nature 387 (1997) 426-430
79. Wild C., Oas T., McDanal C., Bolognesi D., and Matthews T. A synthetic peptide inhibitor of human immunodeficiency virus replication: Correlation between solution structure and viral inhibition. Proc. Natl. Acad. Sci. USA 89 (1992) 10537-10541
80. Wild C.T., Shugars D.C., Greenwell T.K., McDanal C.B., and Matthews T.J. Peptides corresponding to a predictive α-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. USA 91 (1994) 9770-9774
81. Wu L., Gerard N.P., Wyatt R., Choe H., Parolin C., Ruffing N., Borsetti A., Cardoso A.A., Desjardin E., Newman W., Gerard C., and Sodroski J. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384 (1996) 179-183
82. Zhang W., Chipman P.R., Corver J., Johnson P.R., Zhang Y., Mukhopadhyay S., Baker T.S., Strauss J.H., Rossmann M.G., and Kuhn R.J. Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat. Struct. Biol. 10 (2003) 907-912
83. Zhang Y., Corver J., Chipman P.R., Zhang W., Pletnev S.V., Sedlak D., Baker T.S., Strauss J.H., Kuhn R.J., and Rossmann M.G. Structures of immature flavivirus particles. EMBO J. 22 (2003) 2604-2613
84. Zhou G., Ferrer M., Chopra R., Kapoor T.M., Strassmaier T., Weissenhorn W., Skehel J.J., Oprian D., Schreiber S.L., Harrison S.C., and Wiley D.C. The structure of an HIV-1 specific cell entry inhibitor in complex with the HIV-1 gp41 trimeric core. Bioorg. Med. Chem. 8 (2000) 2219-2227
85. Zhang W., Mukhopadhyay S., Pletnev S.V., Baker T.S., Kuhn R.J., and Rossmann M.G. Placement of the structural proteins in Sindbis virus. J. Virol. 76 (2002) 11645-11658